The efficacy and safety of abiraterone acetate in patients with high-risk prostate cancer: a meta-analysis based on six randomized control trials

BACKGROUND: Abiraterone acetate, a CYP17 enzyme inhibitor, can block the synthesis of androgens in the adrenal gland, prostate, and testis. The purpose of this study was to investigate the efficacy and safety of abiraterone acetate in high-risk prostate cancer patients, including metastatic castrati...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Transl Androl Urol
Main Authors: Tan, Guobin, Xuan, Zijun, Li, Zhiqin, Huang, Shuitong, Chen, Guangming, Wu, Yonglu, Chen, Xianxi, Liang, Zhijin, Wu, Aiming
Format: Artigo
Jezik:Inglês
Izdano: AME Publishing Company 2020
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7475664/
https://ncbi.nlm.nih.gov/pubmed/32944530
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau-20-1058
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki